Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Healthcare Drug Manufacturers - Specialty & Generic

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc > Lot of talented people with connections

<< Previous

Bullboard Posts

Next >>

Comment by realitycheck00on Nov 17, 2020 2:17pm

85 Views

Post# 31915655

RE:RE:Lot of talented people with connections

I think you might be confusing this stock or company with the typical Canadian stories where its all about flipping stock. These guys have real biotech backers with long term views and a CEO that has done this before, have you looked at his background?

You think a company with a recent $45M warchest, one of the best teams and prob the most strategic investor bases is going to get smashed? Enlighten me or go away if your not a shareholder like everyone else on here.

<< Previous

Bullboard Posts

Next >>

Xplore Resources to expand position near Surge Lithium Project